Isabel Blancas, Marta Legerén, Lidia Carnerero Córdoba, Carlos Jose Rodriguez Gonzalez, Fernando Rodríguez-Serrano. "Cost-effectiveness of HER2/neu 655 genotyping in managing trastuzumab-induced cardiotoxicity risk in HER2-positive breast cancer patients.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.543